Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

The natural history of community-acquired common colds symptoms assessed over 4-years.

Witek TJ, Ramsey DL, Carr AN, Riker DK.

Rhinology. 2015 Mar;53(1):81-8. doi: 10.4193/Rhin14.149.

PMID:
25756083
2.

A recurrence of benign multicystic peritoneal mesothelioma treated through laparoscopic excision: a case report and review of the literature.

Witek TD, Marchese JW, Farrell TJ.

Surg Laparosc Endosc Percutan Tech. 2014 Apr;24(2):e70-3. doi: 10.1097/SLE.0b013e31828f7269.

PMID:
24686367
3.

[Results of intramedullary fixation in the treatment of multiple fractures of the long bones].

Witek T, Kotela A, Kotela I.

Przegl Lek. 2010;67(5):381-5. Polish.

PMID:
20684342
4.

[The treatment of infection after primary total knee arthroplasty with a focus on the usefulness of Spacer-K].

Kotela I, Kotela A, Witek T, Bednarenko M.

Przegl Lek. 2010;67(5):365-7. Polish.

PMID:
20684338
5.

The MCID of the transition dyspnea index is a total score of one unit.

Mahler DA, Witek TJ Jr.

COPD. 2005 Mar;2(1):99-103. Review.

PMID:
17136969
6.

Airway responses to the inhalation of cotton dust and cotton bract extracts.

Schachter EN, Zuskin E, Buck M, Witek TJ, Godbold J, Roy N, Castranova V, Whitmer M, Siegel PD, Bluhm EC.

Respiration. 2006;73(1):41-7. Epub 2005 Sep 20.

PMID:
16179819
7.

Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.

Casaburi R, Kukafka D, Cooper CB, Witek TJ Jr, Kesten S.

Chest. 2005 Mar;127(3):809-17.

PMID:
15764761
8.

Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease.

Calverley PM, Lee A, Towse L, van Noord J, Witek TJ, Kelsen S.

Thorax. 2003 Oct;58(10):855-60.

9.

Meaningful effect size and patterns of response of the transition dyspnea index.

Witek TJ Jr, Mahler DA.

J Clin Epidemiol. 2003 Mar;56(3):248-55.

PMID:
12725879
10.
11.

One-Year Evaluation of the Safety and Efficacy of Ipratropium Bromide HFA and CFC Inhalation Aerosols in Patients with Chronic Obstructive Pulmonary Disease.

Brazinsky SA, Lapidus RJ, Weiss LA, Ghafouri M, Fagan NM, Witek TJ; ROVENT HFA Study Group.

Clin Drug Investig. 2003;23(3):181-91. doi: 10.2165/00044011-200323030-00004.

PMID:
23340924
12.

A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol.

Donohue JF, van Noord JA, Bateman ED, Langley SJ, Lee A, Witek TJ Jr, Kesten S, Towse L.

Chest. 2002 Jul;122(1):47-55.

PMID:
12114338
13.

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.

Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, Menjoge SS, Serby CW, Witek T Jr.

Eur Respir J. 2002 Feb;19(2):217-24.

14.

Expression of ICAM-1 in nasal epithelium and levels of soluble ICAM-1 in nasal lavage fluid during human experimental rhinovirus infection.

Winther B, Arruda E, Witek TJ, Marlin SD, Tsianco MM, Innes DJ, Hayden FG.

Arch Otolaryngol Head Neck Surg. 2002 Feb;128(2):131-6.

PMID:
11843719
15.

Effective delivery of particles with the HandiHaler dry powder inhalation system over a range of chronic obstructive pulmonary disease severity.

Chodosh S, Flanders JS, Kesten S, Serby CW, Hochrainer D, Witek TJ Jr.

J Aerosol Med. 2001 Fall;14(3):309-15.

PMID:
11693842
16.

Ipratropium bromide hydrofluoroalkane inhalation aerosol is safe and effective in patients with COPD.

Taylor J, Kotch A, Rice K, Ghafouri M, Kurland CL, Fagan NM, Witek TJ Jr; Ipratropium Bromide HFA Study Group.

Chest. 2001 Oct;120(4):1253-61.

PMID:
11591569
17.

Inhaled anticholinergic therapy: applied pharmacology and interesting developments.

Witek TJ Jr, Disse B.

Curr Opin Investig Drugs. 2001 Jan;2(1):53-8. Review. No abstract available.

PMID:
11527013
18.

The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group.

Casaburi R, Briggs DD Jr, Donohue JF, Serby CW, Menjoge SS, Witek TJ Jr.

Chest. 2000 Nov;118(5):1294-302.

PMID:
11083677
19.
20.

Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease.

Littner MR, Ilowite JS, Tashkin DP, Friedman M, Serby CW, Menjoge SS, Witek TJ Jr.

Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 1):1136-42.

PMID:
10764302
21.

Anticholinergic bronchodilators.

Witek TJ Jr.

Respir Care Clin N Am. 1999 Dec;5(4):521-36. Review.

PMID:
10565879
22.

Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial.

Turner RB, Wecker MT, Pohl G, Witek TJ, McNally E, St George R, Winther B, Hayden FG.

JAMA. 1999 May 19;281(19):1797-804.

PMID:
10340366
23.

The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD.

Dorinsky PM, Reisner C, Ferguson GT, Menjoge SS, Serby CW, Witek TJ Jr.

Chest. 1999 Apr;115(4):966-71.

PMID:
10208193
24.

Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD.

Friedman M, Serby CW, Menjoge SS, Wilson JD, Hilleman DE, Witek TJ Jr.

Chest. 1999 Mar;115(3):635-41.

PMID:
10084468
25.

Analysis of inhaled corticosteroid and oral theophylline use among patients with stable COPD from 1987 to 1995.

Van Andel AE, Reisner C, Menjoge SS, Witek TJ.

Chest. 1999 Mar;115(3):703-7.

PMID:
10084479
26.

Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease.

Disse B, Speck GA, Rominger KL, Witek TJ Jr, Hammer R.

Life Sci. 1999;64(6-7):457-64. Review.

PMID:
10069510
27.

Frequency and natural history of rhinovirus infections in adults during autumn.

Arruda E, Pitkäranta A, Witek TJ Jr, Doyle CA, Hayden FG.

J Clin Microbiol. 1997 Nov;35(11):2864-8.

28.

An evaluation of nasal response following different treatment regimes of oxymetazoline with reference to rebound congestion.

Morris S, Eccles R, Martez SJ, Riker DK, Witek TJ.

Am J Rhinol. 1997 Mar-Apr;11(2):109-15.

PMID:
9129752
29.

A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma.

Karpel JP, Schacter EN, Fanta C, Levey D, Spiro P, Aldrich T, Menjoge SS, Witek TJ.

Chest. 1996 Sep;110(3):611-6.

PMID:
8797400
30.

Characterization of daytime sleepiness and psychomotor performance following H1 receptor antagonists.

Witek TJ Jr, Canestrari DA, Miller RD, Yang JY, Riker DK.

Ann Allergy Asthma Immunol. 1995 May;74(5):419-26.

PMID:
7749974
31.

Immunological and respiratory reactions in workers exposed to organic dusts.

Zuskin E, Schachter EN, Kanceljak B, Mustajbegovic J, Witek TJ.

Int Arch Occup Environ Health. 1994;66(5):317-24.

PMID:
7896416
32.
33.
34.

Organic dust disease of airways.

Zuskin E, Schachter EN, Kanceljak B, Witek TJ Jr, Fein E.

Int Arch Occup Environ Health. 1993;65(2):135-40.

PMID:
8253512
35.

The effects of phenindamine tartrate on sleepiness and psychomotor performance.

Witek TJ Jr, Canestrari DA, Miller RD, Yang JY, Riker DK.

J Allergy Clin Immunol. 1992 Dec;90(6 Pt 1):953-61.

PMID:
1360991
36.

Immunological findings in hemp workers.

Zuskin E, Kanceljak B, Schachter EN, Witek TJ, Maayani S, Goswami S, Marom Z, Rienzi N.

Environ Res. 1992 Dec;59(2):350-61.

PMID:
1464288
37.

Evaluation of a bedtime dose of a combination antihistamine/analgesic/decongestant product on antigen challenge the next morning.

Majchel AM, Proud D, Kagey-Sobotka A, Witek TJ Jr, Lichtenstein LM, Naclerio RM.

Laryngoscope. 1992 Mar;102(3):330-4.

PMID:
1545660
38.

Superficial nasal mucosal blood flow and nasal patency following topical oxymetazoline hydrochloride.

Witek TJ Jr, Canestrari DA, Hernandez JR, Miller RD, Yang JY, Riker DK.

Ann Allergy. 1992 Feb;68(2):165-8.

PMID:
1739191
39.

Immunological and respiratory changes in animal food processing workers.

Zuskin E, Kanceljak B, Schachter EN, Witek TJ, Maayani S, Goswami S, Marom Z, Rienzi N.

Am J Ind Med. 1992;21(2):177-91.

PMID:
1536153
40.

Immunological findings and respiratory function in cotton textile workers.

Zuskin E, Kanceljak B, Schachter EN, Witek TJ, Mustajbegovic J, Maayani S, Buck MG, Rienzi N.

Int Arch Occup Environ Health. 1992;64(1):31-7.

PMID:
1399012
41.

Acute ventilatory response to green coffee dust extract.

Zuskin E, Kanceljak B, Witek TJ Jr, Schachter EN.

Ann Allergy. 1991 Mar;66(3):219-24.

PMID:
1900983
42.

A ten-year follow-up study of cotton textile workers.

Zuskin E, Ivankovic D, Schachter EN, Witek TJ Jr.

Am Rev Respir Dis. 1991 Feb;143(2):301-5.

PMID:
1990943
43.

Immunological and respiratory changes in soy bean workers.

Zuskin E, Kanceljak B, Schachter EN, Witek TJ Jr, Marom Z, Goswami S, Maayani S.

Int Arch Occup Environ Health. 1991;63(1):15-20.

PMID:
1856019
44.

Respiratory symptoms and lung function in hemp workers.

Zuskin E, Kanceljak B, Pokrajac D, Schachter EN, Witek TJ Jr.

Br J Ind Med. 1990 Sep;47(9):627-32.

45.

Adherence of skin bacteria to human epithelial cells.

Romero-Steiner S, Witek T, Balish E.

J Clin Microbiol. 1990 Jan;28(1):27-31.

46.

Acute effects of herbal tea dust extracts on lung function.

Zuskin E, Kanceljak B, Witek TJ Jr, Schachter EN.

Chest. 1989 Dec;96(6):1327-31.

PMID:
2684553
47.

The effect of cotton bract extract on respiratory glycoconjugate secretion from human airways in vitro.

Marom Z, Schachter EN, Goswami S, Witek T Jr, Buck M.

J Allergy Clin Immunol. 1989 Nov;84(5 Pt 1):710-7.

PMID:
2478605
48.

Smoking and cotton dust effects in cotton textile workers.

Schachter EN, Kapp MC, Beck GJ, Maunder LR, Witek TJ.

Chest. 1989 May;95(5):997-1003.

PMID:
2707092
49.

Respiratory function in animal food processing workers.

Zuskin E, Mataija M, Pokrajac D, Schachter EN, Witek TJ Jr.

Am J Ind Med. 1989;16(2):179-87.

PMID:
2788998
50.

Bronchial responsiveness after inhalation of cotton bract extract.

Witek TJ Jr, Mazzara CA, Zuskin E, Beck GJ, Buck MG, Schachter EN.

Am Rev Respir Dis. 1988 Dec;138(6):1579-83.

PMID:
3059900

Supplemental Content

Support Center